POLR2I Antibodies

Santa Cruz Biotechnology delivers a wide array of POLR2I monoclonal antibodies for investigating RNA polymerase II in transcription regulation. POLR2I monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). POLR2I, also known as the second largest subunit of RNA polymerase II, plays a critical role in synthesizing messenger RNA (mRNA) and is essential for the transcription of protein-coding genes. RNA polymerase II function is vital for cellular processes such as gene expression regulation, cell differentiation, and response to environmental signals. POLR2I activity has been extensively studied in various diseases, including cancer, highlighting its importance in cellular homeostasis. Researchers can utilize POLR2I monoclonal antibodies to explore transcription mechanisms in both normal and pathological conditions. Understanding POLR2I function contributes to knowledge about fundamental cellular processes and disease development. POLR2I research continues to reveal new insights into gene regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise investigation of POLR2I's role in transcription and disease mechanisms.